References:
1.Lanctôt KL, Hahn-Pedersen JH, Eichinger CS, et al. Burden of illness in people with Alzheimer’s disease: a systematic review of epidemiology, comorbidities and mortality. J Prev Alzheimers Dis 2023; 1–11.
2.Beerten SG, Helsen A, De Lepeleire J, et al. Trends in prevalence and incidence of registered dementia and trends in multimorbidity among patients with dementia in general practice in Flanders, Belgium, 2000–2021: a registry-based, retrospective, longitudinal cohort study. BMJ Open 2022; 12 (11): e063891.
3.Tan ZS, Vasan RS. Thyroid function and Alzheimer’s disease. J Alzheimers Dis 2009; 16 (3): 503–507.
4.Tan ZS, Beiser A, Vasan RS, et al. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med 2008; 168 (14): 1514–1520.
5.Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000; 157 (5): 708–714.
6.García-Martín V, de Hoyos-Alonso MC, Ariza-Cardiel G, et al. Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study. BMC Geriatr 2022; 22 (1): 71.
7.Eikelboom WS, van den Berg E, Singleton EH, et al. Neuropsychiatric and cognitive symptoms across the Alzheimer disease clinical spectrum: cross-sectional and longitudinal associations. Neurology 2021; 97 (13): e1276–e1287.
8.Leung DKY, Chan WC, Spector A, Wong GHY. Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta-analysis. Int J Geriatr Psychiatry 2021; 36 (9): 1330–1344.
9.Botto R, Callai N, Cermelli A, et al. Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline. Neurol Sci 2022; 43 (7): 4107–4124.
